California, November 16, 2022 - EMTRI Corp. ("EMTRI" or the "Company"), a leading cannabis marketing and advisory agency that issues EMT tokens to cannabis cultivators when they disclose batch cultivation data on an Ethereum layer-2 blockchain, announced today that it had launched the EMT  token and a Uniswap token trading pair  as part of its digital marketing campaign.
(I) Company issues/mints EMT tokens as rewards for cannabis cultivators when they disclose cannabis cultivation events, including laboratory reports, to their consumers using the EMTRI app. (II) EMTRI commits to a marketing-spend of at least 13.335% of the cultivators’ wholesale cannabis sales revenues buying-back EMT tokens from Uniswap every month.
EMT Uniswap buybacks may lead to greater awareness of the Company’s products and may drive cannabis consumers to look for truthful, blockchain-proven, EMTRI cultivators’ cannabis. Every EMT bought back is deposited into the EMT Stake & Earn smart contract on Ethereum .
Cultivators may export their earned EMT tokens from inside the EMTRI Ethereum layer-2 blockchain smartphone app to the Ethereum mainnet and may sell their tokens on Uniswap. Alternatively, the cultivator may stake their tokens and earn a yield, paid in EMTs .
“Our agency’s EMT rewards program is 100% non-custodial, as EMTRI adheres to the mantra of ‘not your keys, not your coins’. We’ve seen recently how custodial services like FTX  can simply steal peoples’ tokens. Our agency is committed to blockchain and to raising awareness amongst our cultivators of the benefits of decentralized finance.” stated Eric Kennedy, CEO.
Global Compliance Applications Corp. ("GCAC") (CSE: APP, FSE: 2FA, OTCQB: FUAPF), a leading cannabis compliance platform, announced on March 10, 2022, that it had signed a software license agreement with EMTRI Corp. for EMTRI to use GCAC’s Efixii, an Ethereum layer-2 blockchain, for EMTRI’s Californian cultivators to track lifecycle data for cannabis.
The Uniswap EMTRI marketing token is built and operated by Abbey Technology, and this token has implemented a unique set of smart contract features , including:
EMTRI Corp. is a cannabis marketing and advisory agency whose distribution partners are rewarded for carrying the truth to retail and delivering safe cannabis to consumers who trust EMTRI standards and mark of approval. The EMTRI Ethereum layer-2 blockchain provides better data-driven outcomes for cannabis consumers, one gram at a time. Our cultivator and distributor membership create a stronger, more transparent relationship between the cannabis plant and the consumer. Our smartphone app technology provides an intuitive and truthful feedback loop from the point at which our cultivators conceptualize and plant their cannabis strains and follows the crop through distribution, retail, and consumption. Our app can also be anonymously used by consumers to provide blockchain-protected feedback on the consumed cannabis directly to the cultivator using a simple QR-code scan.
Abbey, a Swiss company, specializes in developing, licensing and operating innovative blockchain technologies. The “Public-Company to Uniswap-Token” marketing platform was invented by Abbey alongside its Ethereum layer-2 high-throughput blockchain software-as-a-service. For information on Uniswap-token marketing campaigns for public companies visit https://abbey.ch.
This news release may include forward-looking information concerning the business of EMTRI. Forward-looking information is based on certain key expectations and assumptions made by the management of EMTRI. Although management of EMTRI believes that the expectations and assumptions on which such forward-looking information is based are reasonable, undue reliance should not be placed on the forward-looking information because EMTRI can give no assurance that they will prove to be correct. Forward-looking statements contained in this news release are made as of the date of this news release. EMTRI disclaims any intent or obligation to update publicly any forward-looking information, whether as a result of new information, future events or results or otherwise, other than as required by applicable securities laws.
No securities regulator has reviewed or accepted responsibility for the adequacy and accuracy of this information.